Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge has advised Beijer Byggmaterial in connection with entering into an agreement to acquire Karl Ekesiöö Bygghandel
Mandate

Vinge has advised Beijer Byggmaterial in connection with entering into an agreement to acquire Karl Ekesiöö Bygghandel

June 25, 2019 M&A

Vinge has advised Beijer Byggmaterial AB (“Beijer Byggmaterial”) in connection with Beijer Byggmaterial entering into an agreement to acquire Karl Ekesiöö Bygghandel AB. Completion of the transaction is subject to customary conditions.

Karl Ekesiöö Bygghandel AB is operating two branches in attractive locations with substantial building activity in the metro-area of Stockholm, (where Beijer Byggmaterial earlier this year acquired the business of Bygg-Ole).

Beijer Byggmaterial is part of Stark Group, the largest retailer and distributor of building materials in the Nordic region with operations in Denmark, Greenland, Norway, Sweden and Finland.

Vinge’s team consisted of, among others, Jonas Bergström, Linda Sengul, Anna Thoms,  Desirée Sjöblom and Jesper Lindvall (M&A), Agnes Perbo (Corporate Commercial), Kristoffer Larsson (Real Property/Lease Agreements) and Sophia Holm (Employment).

Related

Vinge has advised Hansa Biopharma in connection with entering into a financing agreement

 Vinge has advised Hansa Biopharma AB (publ), a commercial-stage biopharmaceutical company on a mission to develop and commercialize innovative, lifesaving and life-altering treatments for patients with rare immunological conditions, listed on Nasdaq Stockholm, in connection with a U.S. convertible note purchase agreement comprising USD 30 million aggregate principal amount of unsecured convertible senior notes.
March 23, 2026

Vinge advises in connection with data center provider EcoDataCenter’s tap issue of SEK 500 million bonds

 Vinge has advised in connection with EcoDC Holding AB (publ)'s tap issue of SEK 500 million senior unsecured bonds under the existing framework of up to SEK 2 billion.
March 19, 2026

Vinge has advised Cinclus Pharma in connection with entering into financing agreement

 Vinge has advised Cinclus Pharma Holding AB (publ), a late-stage clinical pharmaceutical company developing next-generation treatments for gastric acid-related diseases listed on Nasdaq Stockholm, in connection with a long-term structured credit agreement for a total of up to EUR 28 million divided into four tranches, of which two are convertibles.
March 16, 2026